Keyword: GlaxoSmithKline (GSK)

News

GSK Soon to Start Ebola Vaccine Trials

27.10.2014 - GlaxoSmithKline (GSK), the UK's largest pharmaceutical producer, said development of the company's experimental Ebola vaccine candidate is progressing "at an unprecedented rate,"...

News

US Steps up Production of Experimental Ebola Drug

06.10.2014 - The US government is stepping up production of ZMapp, believed to be one the most promising of the Ebola drugs currently under development. The Department of Health and Human...

News

Bayer Closes $14.2 Billion Buy of Merck & Co OTC

06.10.2014 - Bayer has closed its $14.2 billion acquisition of US Merck & Co's $2.2 billion consumer care business after the transaction was approved by anti-trust authorities in all markets...

Markets & Companies

Accelerating the Benefits Achievable from Biocatalysis

02.10.2014 - Recently, Codexis has signed a platform technology license agreement with GlaxoSmithKline (GSK). Under the terms of the agreement, Codexis, a developer of biocatalysts for the...

News

China Fines GSK Nearly $500 Million on Bribery Charges

23.09.2014 - GlaxoSmithkline (GSK), the UK's largest pharmaceutical producer, will pay the Chinese government nearly $500 million in fines after being found guilty of offering bribes to...

Markets & Companies

M&A in Chemicals & Pharmaceuticals

02.09.2014 - The first half suggests that 2014 will be a record year for M&A in pharmaceuticals, with the size of deals having increased substantially over prior years. In 2011, the deal volume...

News

GSK’s Ebola Vaccine Fast-tracked Into Clinical Trials

29.08.2014 - An experimental Ebola vaccine from GlaxoSmithKline is being fast-tracked into clinical trials with human patients, and the company plans to immediately begin building a stockpile...

News

Aesica Appoints New Product Release Manager

19.08.2014 - Aesica, the global contract development and manufacturing organisation (CDMO), announced the appointment of Adam Burgess to the position of Product Release Manager. His role...